GENETIC EPIDEMIOLOGY OF BLOOD PRESSURE RESPONSE TO ANGIOTENSIN RECEPTOR BLOCKER

血管紧张素受体阻滞剂血压反应的遗传流行病学

• 批准号: 7603688
• 负责人: ARLENE B CHAPMAN
• 金额: $ 2.54万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-12-01 至 2007-09-16
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7603688
• 关键词: Age; Angiotensin Receptor; Blood Pressure; Body Size; Candidate Disease Gene; Computer Retrieval of Information on Scientific Projects Database; Funding; Gender; Grant; Hydrochlorothiazide; Institution; Measures; Renin-Angiotensin-Aldosterone System; Research; Research Personnel; Resources; Source; United States National Institutes of Health; Variant; genetic epidemiology; response

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Variation in candidate genes, considered as one or in combination, makes no contribution to the prediction of blood pressure response to hydrochlorothiazide or an angiotensin receptor blocker before or after considering variation in confounders including gender, age, body size, and measures of the renin angiotensin-aldosterone system.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 候选基因的变化被认为是一种或组合的，在考虑对混杂因素的变化之前或之后，对血压对氢氯噻嗪或血管紧张素受体阻滞剂的预测没有任何贡献。